mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.7 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |